Minimum Alveolar Concentration of Isoflurane in Rats Chronically Treated with the Synthetic Cannabinoid WIN 55,212-2

被引:1
作者
Chavez-Monteagudo, Julio Raul [1 ]
Ibancovichi, Jose Antonio [2 ]
Sanchez-Aparicio, Pedro [3 ]
Recillas-Morales, Sergio [3 ]
Osorio-Avalos, Jorge [4 ]
De Paz-Campos, Marco Antonio [5 ]
机构
[1] Univ Nacl Autonoma Mexico, Hosp Pequenas Especies, Fac Estudios Superiores Cuautitlan, Dept Vet Anesthesia & Analgesia, Cuautitlan 54740, Mexico
[2] Univ Autonoma Estado Mexico, Fac Vet Med, Dept Vet Anesthesia & Analgesia, Toluca 50000, Mexico
[3] Univ Autonoma Estado Mexico, Fac Vet Med, Dept Pharmacol, Toluca 50000, Mexico
[4] Univ Autonoma Estado Mexico, Fac Vet Med, Dept Biostat, Toluca 50000, Mexico
[5] Univ Nacl Autonoma Mexico, Hosp Pequenas Especies, Fac Estudios Super Cuautitlan, Dept Pharmacol, Cuautitlan 54740, Mexico
关键词
minimum alveolar concentration MAC; isoflurane; WIN; 55; 212-2; rats; ANESTHETIC REQUIREMENT; ENDOCANNABINOID SYSTEM; HALOTHANE MAC; RECEPTOR; DELTA-9-TETRAHYDROCANNABINOL; CONSTITUENT; BINDS;
D O I
10.3390/ani12070853
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Simple Summary The minimum alveolar concentration of isoflurane (inhaled anesthetic required to prevent movement in 50% of subjects exposed to a supramaximal noxious stimulus) was determined in 24 male rats chronically treated with the synthetic cannabinoid WIN 55,212-2 to evaluate the interaction of isoflurane with chronically administered cannabinoid agonist. The minimum alveolar concentration was determined in one group without treatment, in rats treated for 21 days with WIN 55,212-2, and another group 8 days after stopping treatment for 21 days with cannabinoid. We believe it is necessary to study the effects of chronic consumption of these substances on the requirements of inhalation anesthetics in patients that will be submitted to general anesthesia. The administration for 21 days of WIN 55,212-2 increases the minimum alveolar concentration of isoflurane in rats; this effect does not disappear after 8 days of discontinuing treatment with the synthetic cannabinoid. The minimum alveolar concentration MAC of isoflurane was measured in rats chronically treated with WIN 55,212-2. Methods: The MAC of isoflurane was determined in 24 male rats from expiratory samples at time of tail clamping under the following conditions: without treatment MAC((ISO)), in rats treated for 21 days with WIN 55,212-2 MAC((ISO + WIN55)), and in rats 8 days after stopping treatment with WIN 55,212-2 (MAC(ISO + WIN55 + 8D)). Results: The MAC((ISO)) was 1.32 +/- 0.06. In the MAC((ISO + WIN55)) group, the MAC increased to 1.69 +/- 0.09 (28%, p-value <= (0.0001). Eight days after stopping treatment with WIN55, the MAC did not decrease significantly, 1.67 +/- 0.07 (26%, p-value <= 0.0001). Conclusions: The administration of WIN 55,212-2 for 21 days increases the MAC of isoflurane in rats. This effect does not disappear 8 days after discontinuation of treatment with the synthetic cannabinoid.
引用
收藏
页数:7
相关论文
共 31 条
[1]  
[Anonymous], 2019, WORLD DRUG REPORT 20
[2]   EXAGGERATED ANESTHETIC REQUIREMENTS IN THE PREFERENTIALLY ANESTHETIZED BRAIN [J].
ANTOGNINI, JF ;
SCHWARTZ, K .
ANESTHESIOLOGY, 1993, 79 (06) :1244-1249
[3]   Effect of Acetaminophen Alone and in Combination with Morphine and Tramadol on the Minimum Alveolar Concentration of Isoflurane in Rats [J].
Chavez, Julio R. ;
Ibancovichi, Jose A. ;
Sanchez-Aparicio, Pedro ;
Acevedo-Arcique, Carlos M. ;
Moran-Munoz, Rafael ;
Recillas-Morales, Sergio .
PLOS ONE, 2015, 10 (11)
[4]  
DEVANE WA, 1988, MOL PHARMACOL, V34, P605
[5]   ISOLATION AND STRUCTURE OF A BRAIN CONSTITUENT THAT BINDS TO THE CANNABINOID RECEPTOR [J].
DEVANE, WA ;
HANUS, L ;
BREUER, A ;
PERTWEE, RG ;
STEVENSON, LA ;
GRIFFIN, G ;
GIBSON, D ;
MANDELBAUM, A ;
ETINGER, A ;
MECHOULAM, R .
SCIENCE, 1992, 258 (5090) :1946-1949
[6]   MINIMUM ALVEOLAR ANESTHETIC CONCENTRATION - A STANDARD OF ANESTHETIC POTENCY [J].
EGER, EI ;
SAIDMAN, LJ ;
BRANDSTATER, B .
ANESTHESIOLOGY, 1965, 26 (6P1) :756-+
[7]   ISOLATION, STRUCTURE, AND PARTIAL SYNTHESIS OF AN ACTIVE CONSTITUENT OF HASHISH [J].
GAONI, Y ;
MECHOULAM, R .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1964, 86 (08) :1646-+
[8]   ALTERATION OF ANESTHETIC REQUIREMENT BY AMPHETAMINE [J].
JOHNSTON, RR ;
WAY, WL ;
MILLER, RD .
ANESTHESIOLOGY, 1972, 36 (04) :357-&
[9]   BIOCHEMICAL MAPPING OF NORADRENERGIC NERVES ARISING FROM RAT LOCUS COERULEUS [J].
KOBAYASHI, RM ;
PALKOVITS, M ;
KOPIN, IJ ;
JACOBOWITZ, DM .
BRAIN RESEARCH, 1974, 77 (02) :269-279
[10]   Changes in hippocampal morphology following chronic treatment with the synthetic cannabinoid WIN 55,212-2 [J].
Lawston, J ;
Borella, A ;
Robinson, JK ;
Whitaker-Azmitia, PM .
BRAIN RESEARCH, 2000, 877 (02) :407-410